Distinguished in Magnesium Deficiency

Stefano Cascinu

Via Olgettina 60, 
Milan, IT 
Distinguished in Magnesium Deficiency
Via Olgettina 60, 
Milan, IT 
OverviewLocationsClinical Research

Overview

Stefano Cascinu practices in Milan, Italy. Mr. Cascinu is rated as a Distinguished expert by MediFind in the treatment of Magnesium Deficiency. His top areas of expertise are Colorectal Cancer, Liver Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreaticoduodenectomy, and Gastrectomy.

His clinical research consists of co-authoring 529 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Magnesium Deficiency.

Gender
Male

Locations

Via Olgettina 60, Milan, 20132, Italy
Other Locations
Rozzano, Italy
Modena, Italy
Universita Politecnica delle Marche
Ancona, Italy
Reggio Nell'emilia, Italy
Conca, 60020, Italy
Marche, Italy
Rome, Italy
Treviglio, Italy
Via Conca 60020 Ancona, Via, 60020, Italy
Parma, Italy
Pesaro, 61100, Italy
Messina, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Randomised Phase Ii Study Of Pre-Operative Or Peri-Operative Docetaxel, Oxaliplatin, Capecitabine (Dox) Regimen In Patients With Locally Advanced Resectable Gastric Cancer
A Randomised Phase Ii Study Of Pre-Operative Or Peri-Operative Docetaxel, Oxaliplatin, Capecitabine (Dox) Regimen In Patients With Locally Advanced Resectable Gastric Cancer
Enrollment Status: Completed
Publish Date: January 09, 2025
Intervention Type: Other
Study Phase: Phase 2
Phase Ib/II Study of the Tumour-targeting Human F16IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Paclitaxel in Patients With Advanced Solid Tumours
Phase Ib/II Study of the Tumour-targeting Human F16IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Paclitaxel in Patients With Advanced Solid Tumours
Enrollment Status: Completed
Publish Date: April 15, 2022
Intervention Type: Drug
Study Drug: F16IL2+Paclitaxel
Study Phase: Phase 1/Phase 2
A Phase 1/2 Study of LY3499446 Administered to Patients With Advanced Solid Tumors With KRAS G12C Mutation
A Phase 1/2 Study of LY3499446 Administered to Patients With Advanced Solid Tumors With KRAS G12C Mutation
Enrollment Status: Terminated
Publish Date: November 24, 2021
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
EFFECT: A Randomized Phase II Study to Evaluate the EFficacy and Impact on Function of Two Different Doses of Nab-paclitaxEl in Elderly Patients With advanCed breasT Cancer
EFFECT: A Randomized Phase II Study to Evaluate the EFficacy and Impact on Function of Two Different Doses of Nab-paclitaxEl in Elderly Patients With advanCed breasT Cancer
Enrollment Status: Completed
Publish Date: January 10, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 3 Less Clinical Trials

528 Total Publications

HER2 Pathway in Biliary Tract Cancer: A Snapshot of the Current Understanding and Future Directions.
HER2 Pathway in Biliary Tract Cancer: A Snapshot of the Current Understanding and Future Directions.
Journal: Targeted oncology
Published: February 05, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Cascinu's expertise for a condition
ConditionClose
View All 9 Distinguished Conditions
View All 7 Advanced Conditions
View All 47 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile